Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity (Q39439256)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity (English)

1 reference

Europe PubMed Central

12 September 2017

0 references

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

9

object named as

George F Gao

1 reference

Europe PubMed Central

12 September 2017

object named as

Lipeng Qiu

2

0 references

author name string

Saifeng Wang

1

1 reference

Europe PubMed Central

12 September 2017

Xiaoli Yan

3

1 reference

Europe PubMed Central

12 September 2017

Wensong Jin

4

1 reference

Europe PubMed Central

12 September 2017

Yanzhong Wang

5

1 reference

Europe PubMed Central

12 September 2017

Lizhao Chen

6

1 reference

Europe PubMed Central

12 September 2017

Erjie Wu

7

1 reference

Europe PubMed Central

12 September 2017

Xin Ye

8

1 reference

Europe PubMed Central

12 September 2017

Fusheng Wang

10

1 reference

Europe PubMed Central

12 September 2017

Yu Chen

11

1 reference

Europe PubMed Central

12 September 2017

Zhongping Duan

12

1 reference

Europe PubMed Central

12 September 2017

Songdong Meng

13

1 reference

Europe PubMed Central

12 September 2017

language of work or name

0 references

publication date

1 March 2012

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

55

1 reference

Europe PubMed Central

12 September 2017

730-741

1 reference

Europe PubMed Central

12 September 2017

3

1 reference

Europe PubMed Central

12 September 2017

Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Mechanisms of HBV-related hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Molecular mechanism of p73-mediated regulation of hepatitis B virus core promoter/enhancer II: implications for hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Repression of hepatitis B viral gene expression by transcription factor nuclear factor-kappaB.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Enhancer I predominance in hepatitis B virus gene expression

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Control of hepatitis B virus at the level of transcription.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

miR-122, a paradigm for the role of microRNAs in the liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

microRNA-122 stimulates translation of hepatitis C virus RNA

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Silencing of microRNAs in vivo with 'antagomirs'

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Reciprocal Effects of Micro-RNA-122 on Expression of Heme Oxygenase-1 and Hepatitis C Virus Genes in Human Hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Cyclin G recruits PP2A to dephosphorylate Mdm2

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

A role for the cyclin box in the ubiquitin-mediated degradation of cyclin G1.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

Interferon modulation of cellular microRNAs as an antiviral mechanism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

21 January 2018

The widespread regulation of microRNA biogenesis, function and decay

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of short-term dexamethasone therapy in acute-on-chronic pre-liver failure

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24809

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.24809

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39439256&oldid=1982158891"